Diabetic Nephropathy News and Research

RSS
Diabetic nephropathy is kidney disease or damage that results as a complication of diabetes.
Antisense Therapeutics enrolls acromegalic patients in ATL1103 Phase II trial

Antisense Therapeutics enrolls acromegalic patients in ATL1103 Phase II trial

Fibrotech successfully completes Phase Ia trial of anti-fibrotic compound FT011

Fibrotech successfully completes Phase Ia trial of anti-fibrotic compound FT011

New research aims for better monitoring, treatment for chronic kidney disease

New research aims for better monitoring, treatment for chronic kidney disease

Gastric bypass and cardiovascular disease risk: an interview with Dr. Brethauer, Cleveland Clinic

Gastric bypass and cardiovascular disease risk: an interview with Dr. Brethauer, Cleveland Clinic

ANP reports positive interim results from ATL1103 Phase II clinical trial for acromegaly

ANP reports positive interim results from ATL1103 Phase II clinical trial for acromegaly

Genkyotex announces initiation of GKT137831 Phase II study in patients with diabetic nephropathy

Genkyotex announces initiation of GKT137831 Phase II study in patients with diabetic nephropathy

JDRF partners with Pfizer's CTI to support diabetes research

JDRF partners with Pfizer's CTI to support diabetes research

Researchers discover link between NOX4 enzyme and osteoporosis

Researchers discover link between NOX4 enzyme and osteoporosis

Joslin gets NIH grant to study potential treatment for kidney disease in people with diabetes

Joslin gets NIH grant to study potential treatment for kidney disease in people with diabetes

Findings may help explain why some diabetic women prone to develop kidney failure

Findings may help explain why some diabetic women prone to develop kidney failure

NOXXON completes patient recruitment of NOX-E36 Phase IIa trial for treatment of diabetic nephropathy

NOXXON completes patient recruitment of NOX-E36 Phase IIa trial for treatment of diabetic nephropathy

AbbVie starts Phase 3 clinical study of atrasentan in patients with diabetic nephropathy

AbbVie starts Phase 3 clinical study of atrasentan in patients with diabetic nephropathy

Organic pollutants increase nephropathy risk in diabetes

Organic pollutants increase nephropathy risk in diabetes

Galectin Therapeutics' GR-MD-02 reverses diabetic nephropathy in preclinical study

Galectin Therapeutics' GR-MD-02 reverses diabetic nephropathy in preclinical study

Swift Charities donates $15,262 to Waylon Jennings Fund for Diabetes Research at TGen

Swift Charities donates $15,262 to Waylon Jennings Fund for Diabetes Research at TGen

NOXXON commences NOX-H94 Phase IIa trial to treat anemia of chronic disease

NOXXON commences NOX-H94 Phase IIa trial to treat anemia of chronic disease

Genkyotex announces positive results from GKT137831 Phase I studies on healthy subjects

Genkyotex announces positive results from GKT137831 Phase I studies on healthy subjects

Liver x receptor plays an important role in diabetic nephropathy

Liver x receptor plays an important role in diabetic nephropathy

Data from Genkyotex’s GKT137831 Phase I studies to be presented at Kidney Week 2012

Data from Genkyotex’s GKT137831 Phase I studies to be presented at Kidney Week 2012